secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2026-11-04T22:28:34+00:00
Accession:  0001493152-26-049999
Event type: regulatory
Sentiment:  negative
Materiality: 0.50
Item codes: 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Bio Green Med gets Nasdaq bid-price notice; 180 days to April 27, 2027 to top $1.00
--------------------------------------------------------------------------------

- Nasdaq notice Oct 29, 2026: BGMS bid below $1.00 for 30 straight business days, breaching Listing Rule 5550(a)(2).
- 180-day grace period runs to April 27, 2027; compliance requires 10 consecutive closes at or above $1.00.
- Company cites a reverse split of 1:4 to 1:16, subject to stockholder approval, as a potential remedy tied to the FNRG deal.
- June 4, 2026 BCA with Malaysia's Future NRG Sdn. Bhd. would make FNRG a wholly owned subsidiary via share exchange.
- No immediate effect on trading; S-4 proxy/prospectus effective Oct 8, 2026; signed by CEO Datuk Dr. Doris Wong Sing Ee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000149315226049999/0001493152-26-049999-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000149315226049999/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-049999

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer